Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.
Chintan H KapadiaJilian R MelamedEmily S DayPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2018)
Spherical nucleic acids (SNAs) are highly oriented, well organized, polyvalent structures of nucleic acids conjugated to hollow or solid core nanoparticles. Because they can transfect many tissue and cell types without toxicity, induce minimum immune response, and penetrate various biological barriers (such as the skin, blood-brain barrier, and blood-tumor barrier), they have become versatile tools for the delivery of nucleic acids, drugs, and proteins for various therapeutic purposes. This article describes the unique structures and properties of SNAs and discusses how these properties enable their application in gene regulation, immunomodulation, and drug and protein delivery. It also summarizes current efforts towards clinical translation of SNAs and provides an expert opinion on remaining challenges to be addressed in the path forward to the clinic.
Keyphrases
- blood brain barrier
- nucleic acid
- immune response
- high resolution
- cerebral ischemia
- primary care
- single cell
- oxidative stress
- cell therapy
- photodynamic therapy
- quality improvement
- soft tissue
- drug induced
- clinical practice
- walled carbon nanotubes
- binding protein
- mass spectrometry
- mesenchymal stem cells
- amino acid
- bone marrow
- subarachnoid hemorrhage